[Nephrotoxicity in the perinatal period. Evaluation of drug surveillance centers].
Bavoux
F
F
Bodiou
C
C
Olive
G
G
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D005333:Fetus / Q000187:drug effects*; D005602:France; D006801:Humans; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000139:chemically induced / Q000453:epidemiology / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing
D000806:Angiotensin-Converting Enzyme Inhibitors; D000894:Anti-Inflammatory Agents, Non-Steroidal
Observations de néphrotoxicité en période périnatale. Bilan des Centres de Pharmacovigilance.